Former Co-Owner of New Jersey Marketing Company Admits Role in $8.8 Million Compounded Prescription Drug Scheme

/ Published Sept. 23, 2020

The former co-owner of a New Jersey marketing company today admitted her role in a scheme to defraud public and private health benefits programs of at least $8.8 million for the billing of medically unnecessary compounded prescriptions, U.S. Attorney Craig Carpenito announced.